Population

16.2m

Gross Domestic Product, GDP (2003)

€452.95bn

Healthcare expenditure (2001)

Subscribe >

Health expenditure as proportion of GDP (2002)

Subscribe >

Size of pharmaceutical market (2003) (excluding hospital sales)

Subscribe >

Expenditure on pharmaceuticals as % health expenditure (2002)

Subscribe >

Pharmaceuticals expenditure (proportion of GDP)

Subscribe >

Pharmaceutical market growth rate (2004)

Subscribe >

Local currency

Euro (€)



Summary: Netherlands

Since the 1990s, Netherlands has experimented with some of the toughest cost-containment efforts in the European Union (EU). Generic medicines and parallel imports are encouraged, and pharmacoeconomic criteria are growing in importance. The industry has complained that obtaining reimbursement for new products is too difficult.

Summary of report content

  • Summary
  • How is the healthcare system structured?
  • What size is the pharmaceutical market?
  • Are pharmaceuticals taxed?
  • How are drug prices set?
  • How are prices changed?
  • How are drugs reimbursed?
  • Is there a payback arrangement?
  • Are hospital sales controlled?
  • Are OTC prices regulated?
  • How are pharmaceutical costs controlled?
  • How are generic drugs priced?
  • What are wholesale/pharmacy margins?
  • Is parallel trade influential?
  • What to look out for
  • Glossary
  • Useful Contacts
Your Basket

Your basket is currently empty.

Search News
News
25/04/2005
New Health Insurance Act to come into force on 1 January 2006

Subscribe >

01/01/2005
New Medicines Law to come into force in 2005

Subscribe >

View all articles »

Related Items